>Multi7001 at 16:32, 1 September 2021

2021-09-01T16:32:02Z

New page

{{Short description|Indian multinational pharmaceutical company}}
{{Use Indian English|date=August 2020}}{{Use dmy dates|date=May 2014}}

{{Infobox company
| name = Ipca Laboratories Limited
| logo = File:Ipca Labs logo.svg
| logo_size = 250px
| logo_alt = Ipca Laboratories' logo
| type = [[Public company|Public]]
| traded_as = {{BSE|524494}} {{NSE|IPCALAB}}
| genre =
| foundation = 19 October 1949 ([[Mumbai]])
| founder = K.B. Mehla Dr. N.S. Tibrawala
| location_city = Mumbai, India<ref>{{cite web |url=http://www.ipcalabs.com/contactus/index.php# |title=Ipca Laboratories Ltd. :: Contact Us :: India Offices |publisher=Ipcalabs.com |access-date=1 December 2010 |archive-url=https://web.archive.org/web/20101113002712/http://www.ipcalabs.com/contactus/index.php |archive-date=13 November 2010 |url-status=dead }}</ref>
| location_country =
| locations =
| area_served = Worldwide
| key_people = Premchand Godha, [[Managing Director|MD]],<ref name="Expressindia.com">{{cite web|url=http://www.expressindia.com/fe/daily/20000915/fco15046.html |title=Ipca Laboratories targets Rs 425cr turnover this year |publisher=Expressindia.com |date=15 September 2000 |access-date=2 December 2010}}</ref> Mr. AK Jain, [[Managing Director|JMD]]<ref>{{cite web|url=http://www.expresspharmaonline.com/20100831/pharmalife05.shtml |title=Pawan Kothari|publisher=Expresspharmaonline.com |date=31 August 2010 |access-date=2 December 2010}}</ref>
| industry = [[Pharmaceutical industry|Pharmaceutical]]
| products = [[Pharmaceutical]]s, [[drugs]]
| services =
| market cap =
| revenue = {{profit}} {{INRConvert|15.59|b}}<ref>{{cite web|url=http://www.bseindia.com/bseplus/StockReach/AdvanceStockReach.aspx?scripcode=524494 |title=BSE Plus |publisher=Bseindia.com |access-date=1 December 2010}}</ref> (2010)
| operating_income =
| net_income =
| assets =
| equity =
| owner =
| subsid = CCPL Software,<ref name="Expressindia.com"/> Ipca Traditional Remedies<ref>{{cite web |url=http://www.ayurvednews.com/archives/189 |title=Ipca Laboratories Ltd plans to diversify into Ayurveda business |publisher=AyurvedNews.com |access-date=2 December 2010 |archive-url=https://web.archive.org/web/20110707202456/http://www.ayurvednews.com/archives/189 |archive-date=7 July 2011 |url-status=dead }}</ref>
| num_employees = 12000 (2015)
| homepage = [http://www.ipcalabs.com/ www.ipca.com]
}}

'''Ipca Laboratories''' '''Limited''' is an [[India|Indian multinational]] [[pharmaceutical]] company based in [[Mumbai]], India.

==Background==
It produces Theo bromine, Acetylthiophene, and P-Bromo Toluene as Active Pharmaceutical Ingredients (APIs). Ipca sells these APIs and their intermediates world over.<ref>{{cite web|url=http://business.mapsofindia.com/india-company/i/ipca-laboratories.html |title=Ipca Laboratories |publisher=Business.mapsofindia.com |access-date=1 December 2010}}</ref> It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules.<ref>{{cite web|url=http://www.indiainfoline.com/Research/LeaderSpeak/Interview-of-Mr.-AK-Jain-Executive-Director-Ipca-Laboratories-Ltd/16370585 |title=Interview of Mr. AK Jain, Executive Director, Ipca Laboratories Ltd |publisher=Indiainfoline.com |access-date=1 December 2010}}</ref> The various kinds of drug intermediates that the company manufactures include Theo bromine, Acetylthiophene, and P- Bromo Toluene and promotes over 36 countries of [[Asia]], [[Africa]], [[Commonwealth of Independent States|CIS]], and [[South America]], including Cambodia, Kazakhstan, Kenya, Mauritius, [[Myanmar]], Nigeria, Oman, Russia, Sri Lanka, Sudan, Tanzania, Ukraine, Vietnam and Yemen. The main activities of company are to produce and market pharmaceuticals and drugs. The various products of the company include formulations, drug intermediates, and [[active pharmaceutical ingredients]] (API).

In 2004, Forbes selected Ipca, for the second consecutive year as one among the first 200 'Best under a Billion Company' in Asia.<ref name="indiainfoline1988">{{cite web|url=http://www.indiainfoline.com/Markets/Company/Background/Company-Profile/Ipca-Laboratories-Ltd/524494 |title=Ipca Laboratories Ltd Background details about Company Profile |publisher=Indiainfoline.com |date=9 August 1988 |access-date=1 December 2010}}</ref>

It also got certification from [[US Food and Drug Administration]] (FDA), UK-[[Medicines and Healthcare products Regulatory Agency]] (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-[[Therapeutic Goods Administration]] (TGA). On 29 Jan 2016 the FDA issued a warning letter, WL: 320-16-07,<ref name="FDA.gov">{{cite web|url=https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2016/ucm484910.htm |title=WL: 320-16-07 |publisher=FDA.gov|access-date=16 Feb 2016}}</ref> for failure to comply with good manufacturing processes (GMP) under section 21 of the code of federal regulations (21 CFR).

==History==
It was founded by group of businessmen and medical professionals in 1949.<ref>{{cite web|url=http://www.topnews.in/ipca-laboratories-ltd-term-buy-call-stocksideacom-2255434 |title=IPCA Laboratories Ltd Term Buy Call: StocksIdea.com | TopNews |publisher=Topnews.in |date=15 December 2009 |access-date=1 December 2010}}</ref> In 1975, the management of the company was taken over by [[Amitabh Bachchan]], Ajitabh Bachchan, [[Jaya Bachchan]], M.R. Chandurkar, P.C. Godha.<ref name="indiainfoline1988" />
Corporate office is at Kandivali.

==References==
{{Reflist}}

{{Nifty 200 companies}}

{{Authority control}}

[[Category:Manufacturing companies based in Mumbai]]
[[Category:Pharmaceutical companies of India]]
[[Category:Pharmaceutical companies established in 1949]]
[[Category:Indian companies established in 1949]]
[[Category:Companies listed on the National Stock Exchange of India]]
[[Category:Companies listed on the Bombay Stock Exchange]]

{{India-company-stub}}

Ipca Laboratories - Revision history

>Multi7001 at 16:32, 1 September 2021